Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected with Mycobacterium tuberculosis

Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicity among persons coinfected with hepatitis C virus (HCV) is unknown. We conducted a prospective study among 146 injection drug users with M. tuberculosis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sadaphal, Pankaj, Astemborski, Jacquie, Graham, Neil M. H., Sheely, Laura, Bonds, Margaret, Madison, Azalia, Vlahov, David, Thomas, David L., Sterling, Timothy R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2001
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650436/
https://ncbi.nlm.nih.gov/pubmed/11641824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/323896
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak